share_log

CureVac | SC 13D: Statement of acquisition of beneficial ownership by individuals-Prof. Dr. Friedrich von Bohlen und Halbach(44.3%),Bohlini invest GmbH(0.3%)

CureVac | SC 13D:超过5%持股股东披露文件-Prof. Dr. Friedrich von Bohlen und Halbach(44.3%),Bohlini invest GmbH(0.3%)

2022/05/05 16:01
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息